# New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients

> **NCT02800460** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 35 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **PROCEDURE:** fMRI-3T

## Key facts

- **NCT ID:** NCT02800460
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-10-12
- **Primary completion:** 2025-06-08
- **Final completion:** 2025-12-07
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02800460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02800460, "New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02800460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*